In a filing, Insmed Inc revealed its Chair and CEO Lewis William unloaded Company’s shares for reported $1.52 million on Feb 18 ’25. In the deal valued at $81.03 per share,18,750 shares were sold. As a result of this transaction, Lewis William now holds 334,186 shares worth roughly $26.74 million.
Then, Lewis William sold 6,830 shares, generating $553,442 in total proceeds. Upon selling the shares at $81.03, the Chair and CEO now owns 233,924 shares.
Before that, Bonstein Sara sold 18,322 shares. Insmed Inc shares valued at $1,471,394 were divested by the Chief Financial Officer at a price of $80.31 per share. As a result of the transaction, Bonstein Sara now holds 118,863 shares, worth roughly $9.51 million.
Truist initiated its Insmed Inc [INSM] rating to a Buy in a research note published on April 23, 2024; the price target was $48. A number of analysts have revised their coverage, including Wolfe Research’s analysts, who began to cover the stock in mid February with a ‘”an Outperform”‘ rating. Wells Fargo began covering INSM with “an Overweight” recommendation on December 08, 2023.
Price Performance Review of INSM
On Friday, Insmed Inc [NASDAQ:INSM] saw its stock fall -1.27% to $80.03. Over the last five days, the stock has gained 0.91%. Insmed Inc shares have risen nearly 15.92% since the year began. Nevertheless, the stocks have risen 183.39% over the past one year. While a 52-week high of $84.91 was reached on 02/21/25, a 52-week low of $21.92 was recorded on 01/10/25. SMA at 50 days reached $74.56, while 200 days put it at $68.78.
Levels Of Support And Resistance For INSM Stock
The 24-hour chart illustrates a support level at 78.78, which if violated will result in even more drops to 77.52. On the upside, there is a resistance level at 82.49. A further resistance level may holdings at 84.94. The Relative Strength Index (RSI) on the 14-day chart is 54.89, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 0.95, which suggests price will go down in the next trading period. Percent R suggests that price movement has been low at 59.30%. Stochastics %K at 65.67% indicates the stock is a holding.
The most recent change occurred on July 26, 2023 when Guggenheim began covering the stock and recommended ‘”a Buy”‘ rating along with a $50 price target.
